针对呼吸道病毒的基于mRNA的疫苗的开发取得了进展
Tays Troncoso-Bravo1,2, Mario A Ramírez1, Ricardo A Loaiza1
1Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Immunology
|August 20, 2024
概括
使者核糖核酸 (mRNA) 疫苗提供了一种有希望的新策略,可以对抗流感和RSV等呼吸道病毒. 这项在COVID-19大流行期间经过验证的技术正在探索在儿科和成人呼吸道感染中更广泛的应用.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 急性呼吸道感染 (ARI) 是全球主要的健康问题,特别是在幼儿和老年人中.
- 导致下呼吸道感染的病毒导致显著的发病率和死亡率,包括肺炎和支气管炎.
- 使者核糖核酸 (mRNA) 疫苗技术已经成为打击传染病的强大工具.
研究的目的:
- 审查基于mRNA的针对呼吸道病毒的疫苗的贡献,前景,挑战和影响.
- 突出mRNA技术超越SARS-CoV-2对其他呼吸道病原体的潜力.
- 为呼吸系统健康中mRNA疫苗提供当前景观和未来方向的概述.
主要方法:
- 科学出版物和临床试验数据的文献综述.
- 对mRNA疫苗诱导免疫反应的作用机制的分析.
- 综合关于应用mRNA技术对抗流感,RSV和甲肺病毒的信息.
主要成果:
- mRNA疫苗在预防病毒感染和减少疾病严重程度方面已经证明有效.
- 随着COVID-19的流行,mRNA疫苗平台的快速开发和部署能力得到了强调.
- 对于开发针对一系列呼吸道病毒的疫苗,mRNA技术具有显著的前景.
结论:
- mRNA疫苗代表了预防和控制呼吸道病毒感染的变革性方法.
- 进一步的研究和开发对于克服挑战和扩大mRNA疫苗的使用至关重要.
- mRNA技术的广泛应用为全球呼吸系统健康战略提供了充满希望的未来.
相关概念视频
00:36Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K